CrossRef The progress of molecules and strategies for the treatment of HBV infection Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang Frontiers in Cellular and Infection Microbiology .2023;[Epub] CrossRef Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen, James Fung Expert Review of Gastroenterology & Hepatology .2023
The combined weight loss effect is generally beneficial for patients with obesity and type 2 diabetes, but monitoring is essential to ensure weight loss remains within healthy parameters
2021 Feb;31 (2):107-125
Key Distinctions How is Retatrutide different from other GLP-1 receptor agonists
It is not approved for human or veterinary therapeutic use, self-administration, or any clinical application